Product image of Erleada (Apalutamide) supplied by GNH India

Erleada

Active Ingredient:
Apalutamide
Origin:
EU

Erleada (Apalutamide)

Erleada (Apalutamide) is an oral medication used to treat certain types of prostate cancer. This prescription drug works by blocking androgen receptors, which can help slow the progression of the disease. Learn more about Erleada's uses and effects.

Manufacturer / TM Owner

Janssen-Cilag International Nv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Erleada is primarily used in the treatment of prostate cancer. It is often prescribed for non-metastatic castration-resistant prostate cancer (nmCRPC) to delay metastasis. The medication works by targeting androgen receptors, which play a role in the growth of prostate cancer cells. Patients should consult their healthcare provider to understand what Erleada is used for and whether it is suitable for their condition.

Side Effects

  • Common effects of Erleada may include fatigue, rash, and nausea. Some users might experience joint pain or swelling. It is important to note that individual responses to the medication can vary, and not everyone will experience these effects. Always discuss potential side effects with a healthcare professional.

Precautions & Warnings

  • Erleada should be handled with care and stored as directed. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should inform their doctor about any allergies or other medications they are taking to avoid potential interactions.

Avoid Interactions

  • Erleada may interact with certain medications, including those metabolized by the liver's CYP2C8 and CYP3A4 enzymes. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, alcohol consumption should be moderated while taking Erleada.

Frequently Asked Questions

Erleada is used to treat non-metastatic castration-resistant prostate cancer (nmCRPC) to delay the spread of cancer.

Erleada is taken orally, typically once daily. Follow the specific instructions provided by your healthcare provider.

Common side effects may include fatigue, rash, nausea, and joint pain. Individual experiences can vary.

Erleada may interact with certain medications. Always consult a healthcare provider before combining it with other drugs.

Long-term use of Erleada should be monitored by a healthcare provider to ensure safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Apalutamide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT